Glutathione, vitamin E and oxidative stress in coronary artery disease: relevance of age and gender

Background  Observational studies suggest that low levels of antioxidants are associated with high risk for coronary artery disease (CAD). We investigated whether the biomarkers of oxidative balance undergo the same modifications in all CAD patient groups, regardless of gender and age.

[1]  C. Stefanadis,et al.  The role of oxidative stress in atherosclerosis. , 2009, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[2]  J. Manson,et al.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2008, JAMA.

[3]  M. Schachter,et al.  Vitamins and cardiovascular disease , 2008, British Journal of Nutrition.

[4]  P. Matarrese,et al.  Redox state, cell death and autoimmune diseases: a gender perspective. , 2008, Autoimmunity reviews.

[5]  J. Werba,et al.  A new compound-specific pleiotropic effect of statins: modification of plasma gamma-tocopherol levels. , 2007, Atherosclerosis.

[6]  D. Kromhout.  Fatty acids, antioxidants, and coronary heart disease from an epidemiological perspective , 2007, Lipids.

[7]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[8]  K. Shimada,et al.  Redox imbalance in patients with coronary artery disease showing progression of atherosclerotic lesions. , 2006, Journal of cardiology.

[9]  E. Sarandöl,et al.  Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. , 2006, Clinical biochemistry.

[10]  S. Ueda,et al.  What we learnt from randomized clinical trials and cohort studies of antioxidant vitamin? Focus on vitamin E and cardiovascular disease. , 2006, Current pharmaceutical biotechnology.

[11]  W. Siems,et al.  Clinical oxidation parameters of aging , 2006, Free radical research.

[12]  F. Veglia,et al.  Age- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index , 2006, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[13]  F. Violi,et al.  Antioxidants and cardiovascular disease. , 2005, Current opinion in investigational drugs.

[14]  J. Keaney,et al.  Role of oxidative modifications in atherosclerosis. , 2004, Physiological reviews.

[15]  S. Ibayashi,et al.  Relationship Between Plasma Glutathione Levels and Cardiovascular Disease in a Defined Population: The Hisayama Study , 2004, Stroke.

[16]  D. Lawlor,et al.  Those confounded vitamins: what can we learn from the differences between observational versus randomised trial evidence? , 2004, The Lancet.

[17]  P. Toutouzas,et al.  Oxidative Stress, Antioxidant Vitamins, and Atherosclerosis , 2003, Herz.

[18]  E. Topol,et al.  Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials , 2003, The Lancet.

[19]  J. Jankowski,et al.  The Antioxidant Acetylcysteine Reduces Cardiovascular Events in Patients With End-Stage Renal Failure: A Randomized, Controlled Trial , 2003, Circulation.

[20]  J. Selhub,et al.  The effect of N-acetylcysteine on plasma total homocysteine levels in hemodialysis: a randomized, controlled study. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  P. Tangkijvanich,et al.  The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients. , 2003, Clinical hemorheology and microcirculation.

[22]  M. Gursu,et al.  Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. , 2002, Archives of medical research.

[23]  I. Puddey,et al.  Evidence for the nitration of gamma-tocopherol in vivo: 5-nitro-gamma-tocopherol is elevated in the plasma of subjects with coronary heart disease. , 2002, The Biochemical journal.

[24]  M. Rubenfire,et al.  Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease. , 2002, The Journal of laboratory and clinical medicine.

[25]  F. Granado,et al.  Plasma status of retinol, α- and γ-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study , 2002 .

[26]  F. Granado,et al.  Plasma status of retinol, alpha- and gamma-tocopherols, and main carotenoids to first myocardial infarction: case control and follow-up study. , 2002, Nutrition.

[27]  H. Daida,et al.  Association of serum antioxidant capacity with coronary artery disease in middle-aged men. , 2001, Japanese heart journal.

[28]  M. Haidari,et al.  Enhanced susceptibility to oxidation and diminished vitamin E content of LDL from patients with stable coronary artery disease. , 2001, Clinical chemistry.

[29]  R. Belardinelli,et al.  Oxidative stress and homocysteine in coronary artery disease. , 2001, Clinical chemistry.

[30]  A. Quyyumi,et al.  N-acetylcysteine improves coronary and peripheral vascular function. , 2001, Journal of the American College of Cardiology.

[31]  Á. Hernanz,et al.  Changes in the intracellular homocysteine and glutathione content associated with aging. , 2000, Life sciences.

[32]  H. Payette,et al.  Direct correlation of glutathione and ascorbate and their dependence on age and season in human lymphocytes. , 2000, The American journal of clinical nutrition.

[33]  Á. Hernanz,et al.  Homocysteine and other thiol compounds in ageing. , 2000, BioFactors.

[34]  W. Pryor.  Vitamin E and heart disease: basic science to clinical intervention trials. , 2000, Free radical biology & medicine.

[35]  U. Beisiegel,et al.  Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of α-carotene and γ-tocopherol , 1999 .

[36]  R. Paroni,et al.  Free and total malondialdehyde assessment in biological matrices by gas chromatography-mass spectrometry: what is needed for an accurate detection. , 1999, Analytical biochemistry.

[37]  U. Beisiegel,et al.  Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. , 1999, Atherosclerosis.

[38]  H. Inoue,et al.  Vitamin E deficiency in variant angina. , 1996, Circulation.

[39]  S. Yusuf,et al.  The Antioxidant Vitamins and Cardiovascular Disease: A Critical Review of Epidemiologic and Clinical Trial Data , 1995, Annals of Internal Medicine.

[40]  J. Kuo,et al.  Effect of ageing on human plasma glutathione concentrations as determined by high-performance liquid chromatography with fluorimetric detection. , 1995, Journal of chromatography. B, Biomedical applications.

[41]  G. Burton.  Vitamin E: molecular and biological function , 1994, Proceedings of the Nutrition Society.

[42]  Relationship between the extent of coronary artery disease and indicators of free radical activity. , 1992, Clinical cardiology.